Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.

Kroksveen AC, Guldbrandsen A, Vedeler C, Myhr KM, Opsahl JA, Berven FS.

Acta Neurol Scand Suppl. 2012;(195):90-6. doi: 10.1111/ane.12029.

PMID:
23278663
2.

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, Killestein J, Nielsen J, Vrenken H, Popescu V, Dijkstra CD, Jimenez CR.

Mult Scler. 2011 Jul;17(7):838-50. doi: 10.1177/1352458511399614. Epub 2011 Apr 19.

PMID:
21505015
3.

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.

Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellström S, Marko-Varga G, Végvári A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T.

J Proteomics. 2010 Apr 18;73(6):1117-32. doi: 10.1016/j.jprot.2010.01.004. Epub 2010 Jan 20.

PMID:
20093204
4.

Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.

Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.

Ann Neurol. 2012 May;71(5):614-23. doi: 10.1002/ana.22633.

PMID:
22522477
5.

Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.

Takahashi K, Kurihara Y, Suzuki Y, Goshima Y, Tanaka F, Takei K.

JAMA Neurol. 2015 Feb;72(2):176-9. doi: 10.1001/jamaneurol.2014.3613.

PMID:
25437093
6.

Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.

Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET.

Mult Scler. 2012 Aug;18(8):1081-91. doi: 10.1177/1352458511433303. Epub 2012 Jan 17.

PMID:
22252467
7.

CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.

Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J.

Neurosci Lett. 2009 Mar 13;452(2):214-7. doi: 10.1016/j.neulet.2009.01.057. Epub 2009 Jan 29.

PMID:
19383442
8.

Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome.

Sladkova V, Mareš J, Lubenova B, Zapletalova J, Stejskal D, Hlustik P, Kanovsky P.

Neurol Res. 2011 May;33(4):415-20. doi: 10.1179/016164110X12816242542535.

PMID:
21535941
9.

Cerebrospinal fluid proteome profile in multiple sclerosis.

Lehmensiek V, Süssmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, Tumani H.

Mult Scler. 2007 Aug;13(7):840-9.

PMID:
17881397
10.

Human kallikrein 6 cerebrospinal levels are elevated in multiple sclerosis.

Hebb AL, Bhan V, Wishart AD, Moore CS, Robertson GS.

Curr Drug Discov Technol. 2010 Jun;7(2):137-40.

PMID:
20836755
11.

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

Kroksveen AC, Aasebø E, Vethe H, Van Pesch V, Franciotta D, Teunissen CE, Ulvik RJ, Vedeler C, Myhr KM, Barsnes H, Berven FS.

J Proteomics. 2013 Jan 14;78:312-25. doi: 10.1016/j.jprot.2012.09.037. Epub 2012 Oct 8.

PMID:
23059536
12.

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

Brettschneider J, Maier M, Arda S, Claus A, Süssmuth SD, Kassubek J, Tumani H.

Mult Scler. 2005 Jun;11(3):261-5.

PMID:
15957504
13.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
14.

Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.

Elovaara I, Ukkonen M, Leppäkynnäs M, Lehtimäki T, Luomala M, Peltola J, Dastidar P.

Arch Neurol. 2000 Apr;57(4):546-51.

PMID:
10768630
15.

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.

Romme Christensen J, Börnsen L, Khademi M, Olsson T, Jensen PE, Sørensen PS, Sellebjerg F.

Mult Scler. 2013 Jun;19(7):877-84. doi: 10.1177/1352458512466929. Epub 2012 Nov 24.

PMID:
23178691
16.

Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.

Verbeek MM, Notting EA, Faas B, Claessens-Linskens R, Jongen PJ.

Acta Neurol Scand. 2010 May;121(5):309-14. doi: 10.1111/j.1600-0404.2009.01242.x. Epub 2009 Nov 19.

PMID:
19925532
17.

Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.

Matsushita T, Tateishi T, Isobe N, Yonekawa T, Yamasaki R, Matsuse D, Murai H, Kira J.

PLoS One. 2013 Apr 18;8(4):e61835. doi: 10.1371/journal.pone.0061835. Print 2013.

18.

Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.

Obradović D, Kataranovski M, Dincić E, Obradović S, Colić M.

Vojnosanit Pregl. 2012 Feb;69(2):151-6.

PMID:
22500369
19.

Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.

Collins MA, An J, Hood BL, Conrads TP, Bowser RP.

J Proteome Res. 2015 Nov 6;14(11):4486-501. doi: 10.1021/acs.jproteome.5b00804. Epub 2015 Oct 8.

PMID:
26401960
20.

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

Burman J, Svenningsson A.

J Neuroimmunol. 2016 Mar 15;292:40-4. doi: 10.1016/j.jneuroim.2016.01.008. Epub 2016 Jan 16.

PMID:
26943957

Supplemental Content

Support Center